BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, Frei P, Stickel F, Dill MT, Seifert B, Ferrari HA, von Eckardstein A, Bochud PY, Müllhaupt B, Geier A; Swiss Hepatitis C Cohort Study Group. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012;32:635-43. [PMID: 22151003 DOI: 10.1111/j.1478-3231.2011.02674.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Königshofer P, Brusilovskaya K, Petrenko O, Hofer BS, Schwabl P, Trauner M, Reiberger T. Nuclear Receptors in Liver Fibrosis. Biochim Biophys Acta Mol Basis Dis 2021;:166235. [PMID: 34339839 DOI: 10.1016/j.bbadis.2021.166235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Sriphoosanaphan S, Thanapirom K, Kerr SJ, Suksawatamnuay S, Thaimai P, Sittisomwong S, Sonsiri K, Srisoonthorn N, Teeratorn N, Tanpowpong N, Chaopathomkul B, Treeprasertsuk S, Poovorawan Y, Komolmit P. Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial. PeerJ 2021;9:e10709. [PMID: 33614272 DOI: 10.7717/peerj.10709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zhyvytsia DH, Tsariova OV. СИРОВАТКОВИЙ ВМІСТ 25-(OH) ВІТАМІНУ D НЕ ВПЛИВАЄ НА ЕФЕКТИВНІСТЬ БЕЗІНТЕРФЕРОНОВИХ РЕЖИМІВ ЛІКУВАННЯ ХВОРИХ НА HCV-ІНФЕКЦІЮ. ІХ 2020. [DOI: 10.11603/1681-2727.2020.3.11550] [Reference Citation Analysis]
4 Mosaad H, Emam EA, Hamed EF, El Demerdash EA, Hussein S. Vitamin D receptor gene polymorphism and hepatocellular carcinoma in chronic hepatitis C patients. Egypt Liver Journal 2020;10. [DOI: 10.1186/s43066-020-00063-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Waldenström J, Nyström K, Nilsson S, Norkrans G, Ydreborg M, Langeland N, Mørch K, Westin J, Lagging M. The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection. PLoS One 2020;15:e0237840. [PMID: 32822420 DOI: 10.1371/journal.pone.0237840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Jahn D, Geier A. Transcriptional control of cells by vitamin D and its role in liver health and disease. Molecular Nutrition 2020. [DOI: 10.1016/b978-0-12-811907-5.00030-0] [Reference Citation Analysis]
7 Li YP, Wang MQ, Deng HL, Li M, Zhang X, Dang SS, Zhai S. Association of polymorphisms in the vitamin D receptor gene with susceptibility to and severity of hand, foot, and mouth disease caused by coxsackievirus A16. J Med Virol 2020;92:271-8. [PMID: 31587312 DOI: 10.1002/jmv.25603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Raafat Rowida I, Eshra KA, El-Sharaby RM, Eissa R, Saied SM, Amer I, El Sharawy S. Apa1 (rs7975232) SNP in the vitamin D receptor is linked to hepatocellular carcinoma in hepatitis C virus cirrhosis. Br J Biomed Sci 2020;77:53-7. [PMID: 31682785 DOI: 10.1080/09674845.2019.1680166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Thaimai P, Wasitthankasem R, Poovorawan Y, Komolmit P. Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C. PeerJ 2019;7:e7666. [PMID: 31565578 DOI: 10.7717/peerj.7666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Arai T, Atsukawa M, Tsubota A, Koeda M, Yoshida Y, Okubo T, Nakagawa A, Itokawa N, Kondo C, Nakatsuka K, Masu T, Kato K, Shimada N, Hatori T, Emoto N, Kage M, Iwakiri K. Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dig Liver Dis 2019;51:1036-42. [PMID: 30683615 DOI: 10.1016/j.dld.2018.12.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
11 Barooah P, Saikia S, Bharadwaj R, Sarmah P, Bhattacharyya M, Goswami B, Medhi S. Role of VDR, GC, and CYP2R1 Polymorphisms in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients. Genet Test Mol Biomarkers 2019;23:325-31. [PMID: 30942619 DOI: 10.1089/gtmb.2018.0170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
12 Ruiz JL, François A. Primeros registros precisos de <em>Trox strandi</em> Balthasar, 1936 (Coleoptera: Trogidae) en Marruecos y observaciones sobre su hábitat y variabilidad morfológica. GRAELLSIA 2018;74:082. [DOI: 10.3989/graellsia.2018.v74.214] [Reference Citation Analysis]
13 Udomsinprasert W, Jittikoon J. Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies. Biomed Pharmacother. 2019;109:1351-1360. [PMID: 30551386 DOI: 10.1016/j.biopha.2018.10.140] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
14 Triantos C, Aggeletopoulou I, Kalafateli M, Spantidea PI, Vourli G, Diamantopoulou G, Tapratzi D, Michalaki M, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis. Sci Rep 2018;8:14065. [PMID: 30218108 DOI: 10.1038/s41598-018-32482-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
15 Hu WL, Ren H, Xu BF, Zhang JP, Zhang RL, Wang QQ, Zhang TT. Evaluation of IL-17A, IL-17F, IL-23R, VDR, CCL2, CCL5, CCR2, and CCR5 gene polymorphisms and expression in Chinese individuals with syphilis. J Cell Biochem 2018;119:10151-64. [PMID: 30171709 DOI: 10.1002/jcb.27352] [Reference Citation Analysis]
16 Jin CN, Chen JD, Sheng JF. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new? Eur J Gastroenterol Hepatol 2018;30:741-6. [PMID: 29664746 DOI: 10.1097/MEG.0000000000001134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
17 Kramer H, Syed D, Durazo-arvizu R, Camacho P, Hoofnagle A, Cotler S. Total 25-hydroxyvitamin D but not free 25-hydroxyvitamin D is associated with vitamin D binding globulin in adults with cirrhosis. EMIJ 2018;6. [DOI: 10.15406/emij.2018.06.00171] [Reference Citation Analysis]
18 Khan S, Ali A, Khan S, Bakillah A, Damanhouri G, Khan A, Makki A, AlAnsari I, Banu N. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D. Nutr Metab (Lond) 2018;15:13. [PMID: 29449867 DOI: 10.1186/s12986-018-0251-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
19 Gayam V, Mandal AK, Khalid M, Mukhtar O, Gill A, Garlapati P, Tiongson B, Sherigar J, Mansour M, Mohanty S. Association Between Vitamin D Levels and Treatment Response to Direct-Acting Antivirals in Chronic Hepatitis C: A Real-World Study. Gastroenterology Res 2018;11:309-16. [PMID: 30116431 DOI: 10.14740/gr1072w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wu DB, Wang ML, Chen EQ, Tang H. New insights into the role of vitamin D in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2018;12:287-94. [PMID: 29140126 DOI: 10.1080/17474124.2018.1406307] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
21 Özerkan D, Özsoy N, Akbulut KG, Güney Ş, Öztürk G. The protective effect of vitamin D against carbon tetrachloride damage to the rat liver. Biotech Histochem 2017;92:513-23. [PMID: 28910170 DOI: 10.1080/10520295.2017.1361549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Azevedo LA, Matte U, Silveira TR, Bonfanti JW, Bruch JP, Álvares-da-Silva MR. Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C. Ann Hepatol 2017;16:742-8. [PMID: 28809744 DOI: 10.5604/01.3001.0010.2748] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Komolmit P, Kimtrakool S, Suksawatamnuay S, Thanapirom K, Chattrasophon K, Thaimai P, Chirathaworn C, Poovorawan Y. Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study. Sci Rep 2017;7:8905. [PMID: 28827788 DOI: 10.1038/s41598-017-09512-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
24 de Azevedo LA, Matte U, da Silveira TR, Álvares-da-Silva MR. Genetic variants underlying vitamin D metabolism and VDR-TGFβ-1-SMAD3 interaction may impact on HCV progression: a study based on dbGaP data from the HALT-C study. J Hum Genet 2017;62:969-77. [PMID: 28703134 DOI: 10.1038/jhg.2017.75] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
25 Hiramatsu K, Matsuda H, Nemoto T, Nosaka T, Saito Y, Naito T, Takahashi K, Ofuji K, Ohtani M, Suto H, Yasuda T, Hida Y, Kimura H, Soya Y, Nakamoto Y. Identification of novel variants in HLA class II region related to HLA DPB1 expression and disease progression in patients with chronic hepatitis C. J Med Virol 2017;89:1574-83. [PMID: 28332201 DOI: 10.1002/jmv.24814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Oliveira KS, Buss C, Tovo CV. Is there an association between vitamin D and liver fibrosis in patients with chronic hepatitis C? Arq Gastroenterol 2017;54:57-9. [PMID: 28079241 DOI: 10.1590/S0004-2803.2017v54n1-11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
27 Dadabhai AS, Saberi B, Lobner K, Shinohara RT, Mullin GE. Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data. World J Hepatol 2017; 9(5): 278-287 [PMID: 28261385 DOI: 10.4254/wjh.v9.i5.278] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
28 Abdelsalam A, Rashed L, Salman T, Hammad L, Sabry D. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C. J Dig Dis 2016;17:547-53. [PMID: 27128845 DOI: 10.1111/1751-2980.12353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
29 Belle A, Gizard E, Conroy G, Lopez A, Bouvier-Alias M, Rouanet S, Peyrin-Biroulet L, Pawlotsky JM, Bronowicki JP. 25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients. United European Gastroenterol J 2017;5:69-75. [PMID: 28405324 DOI: 10.1177/2050640616640157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
30 Konstantakis C, Tselekouni P, Kalafateli M, Triantos C. Vitamin D deficiency in patients with liver cirrhosis. Ann Gastroenterol 2016;29:297-306. [PMID: 27366029 DOI: 10.20524/aog.2016.0037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
31 Gabr SA, Alghadir AH, Allam AA, Ajarem J, Al-Basher G, Abdel-Maksoud MA, Ghfar AA, Aboud A. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4. Clin Interv Aging 2016;11:523-33. [PMID: 27217734 DOI: 10.2147/CIA.S104599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
32 Shaker O, Nassar Y, Ayoub S, Elrazki M, Zahra A. Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4. J Clin Lab Anal 2016;30:1021-7. [PMID: 27087054 DOI: 10.1002/jcla.21974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
33 Wu M, Yue M, Huang P, Zhang Y, Xie C, Yu R, Li J, Wang J. Vitamin D level and vitamin D receptor genetic variations contribute to HCV infection susceptibility and chronicity in a Chinese population. Infect Genet Evol 2016;41:146-52. [PMID: 27063396 DOI: 10.1016/j.meegid.2016.03.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
34 Xia SL, Lin XX, Guo MD, Zhang DG, Zheng SZ, Jiang LJ, Jin J, Lin XQ, Ding R, Jiang Y. Association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with Crohn's disease in Chinese patients. J Gastroenterol Hepatol 2016;31:795-801. [PMID: 26513524 DOI: 10.1111/jgh.13221] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
35 Jolliffe DA, Walton RT, Griffiths CJ, Martineau AR. Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies. J Steroid Biochem Mol Biol 2016;164:18-29. [PMID: 26686945 DOI: 10.1016/j.jsbmb.2015.12.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 9.4] [Reference Citation Analysis]
36 Zhang Z, Yu X, Fang X, Liang A, Yu Z, Gu P, Zeng Y, He J, Zhu H, Li S, Fan D, Han F, Zhang L, Yi X. Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis. Sci Rep 2015;5:17638. [PMID: 26627341 DOI: 10.1038/srep17638] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
37 Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol 2015; 21(41): 11552-11566 [PMID: 26556986 DOI: 10.3748/wjg.v21.i41.11552] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
38 Luo YQ, Wu XX, Ling ZX, Cheng YW, Yuan L, Xiang C. Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis. J Zhejiang Univ Sci B. 2014;15:900-906. [PMID: 25294379 DOI: 10.1631/jzus.b1400073] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
39 Wu MP, Zhang JW, Huang P, Han YP, Zhang Y, Peng ZH, Wang J, Zhu P, Su J, Yu RB, Li J, Yue M. Genetic variations in vitamin D receptor were associated with the outcomes of hepatitis C virus infection among Chinese population. J Hum Genet 2016;61:129-35. [PMID: 26446365 DOI: 10.1038/jhg.2015.117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
40 Reda R, Abbas AA, Mohammed M, El Fedawy SF, Ghareeb H, El Kabarity RH, Abo-Shady RA, Zakaria D. The Interplay between Zinc, Vitamin D and, IL-17 in Patients with Chronic Hepatitis C Liver Disease. J Immunol Res. 2015;2015:846348. [PMID: 26504859 DOI: 10.1155/2015/846348] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
41 Coppola N, Pisaturo M, Sagnelli C, Onorato L, Sagnelli E. Role of genetic polymorphisms in hepatitis C virus chronic infection. World J Clin Cases 2015; 3(9): 807-822 [PMID: 26380828 DOI: 10.12998/wjcc.v3.i9.807] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
42 Pontoriero AC, Trinks J, Hulaniuk ML, Caputo M, Fortuny L, Pratx LB, Frías A, Torres O, Nuñez F, Gadano A, Argibay P, Corach D, Flichman D. Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations. BMC Genet 2015;16:93. [PMID: 26219465 DOI: 10.1186/s12863-015-0255-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
43 Mandorfer M, Payer BA, Schwabl P, Steiner S, Ferlitsch A, Aichelburg MC, Stättermayer AF, Ferenci P, Obermayer-Pietsch B, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. Liver Int 2015;35:876-85. [PMID: 24905495 DOI: 10.1111/liv.12615] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
44 Iruzubieta P, Terán &, Crespo J, Fábrega E. Vitamin D deficiency in chronic liver disease. World J Hepatol 2014; 6(12): 901-915 [PMID: 25544877 DOI: 10.4254/wjh.v6.i12.901] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
45 Chen EQ, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hepatobiliary Pancreat Dis Int 2014;13:580-5. [PMID: 25475859 DOI: 10.1016/s1499-3872(14)60295-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
46 Vergniol J, de Lédinghen V. HCV: Fibrosis Progression. Curr Hepatology Rep 2014;13:265-72. [DOI: 10.1007/s11901-014-0247-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Lara J, López-Labrador F, González-Candelas F, Berenguer M, Khudyakov YE. Computational models of liver fibrosis progression for hepatitis C virus chronic infection. BMC Bioinformatics 2014;15 Suppl 8:S5. [PMID: 25081062 DOI: 10.1186/1471-2105-15-S8-S5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
48 Gerova DI, Galunska BT, Ivanova II, Kotzev IA, Tchervenkov TG, Balev SP, Svinarov DA. Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic hepatitis C viral infection. Scand J Clin Lab Invest. 2014;74:665-672. [PMID: 25005344 DOI: 10.3109/00365513.2014.930710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
49 Hung CH, Chiu YC, Hu TH, Chen CH, Lu SN, Huang CM, Wang JH, Lee CM. Significance of vitamin d receptor gene polymorphisms for risk of hepatocellular carcinoma in chronic hepatitis C. Transl Oncol 2014;7:503-7. [PMID: 24894441 DOI: 10.1016/j.tranon.2014.05.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
50 Anty R, Tonohouan M, Ferrari-Panaia P, Piche T, Pariente A, Anstee QM, Gual P, Tran A. Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients. Clin Transl Gastroenterol. 2014;5:e56. [PMID: 24871371 DOI: 10.1038/ctg.2014.6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
51 Amanzada A, Goralczyk AD, Moriconi F, van Thiel DH, Ramadori G, Mihm S. Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection. J Med Virol. 2013;85:1534-1541. [PMID: 23852677 DOI: 10.1002/jmv.23632] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
52 Thompson A, Clark P, Aghemo A. Hepatitis C Virus. Handbook of Pharmacogenomics and Stratified Medicine 2014. [DOI: 10.1016/b978-0-12-386882-4.00037-2] [Reference Citation Analysis]
53 Meer AJ, Maan R, Knegt RJ, Veldt BJ. Natural History of HCV-induced Liver Disease. Curr Hepatitis Rep 2013;12:251-60. [DOI: 10.1007/s11901-013-0195-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Guzmán-Fulgencio M, García-Álvarez M, Berenguer J, Jiménez-Sousa MÁ, Cosín J, Pineda-Tenor D, Carrero A, Aldámiz T, Alvarez E, López JC, Resino S. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients. J Infect. 2014;68:176-184. [PMID: 24184809 DOI: 10.1016/j.jinf.2013.10.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
55 Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M. Association between vitamin D and hepatitis C virus infection: A meta-analysis. World J Gastroenterol 2013; 19(35): 5917-5924 [PMID: 24124339 DOI: 10.3748/wjg.v19.i35.5917] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
56 Wang JB, Abnet CC, Chen W, Dawsey SM, Fan JH, Yin LY, Yin J, Major JM, Taylor PR, Qiao YL. Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Br J Cancer. 2013;109:1997-2004. [PMID: 24008664 DOI: 10.1038/bjc.2013.546] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
57 Han YP, Kong M, Zheng S, Ren Y, Zhu L, Shi H, Duan Z. Vitamin D in liver diseases: from mechanisms to clinical trials. J Gastroenterol Hepatol 2013;28 Suppl 1:49-55. [PMID: 23855296 DOI: 10.1111/jgh.12016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
58 Macaluso FS, Maida M, Minissale MG, Li Vigni T, Attardo S, Orlando E, Petta S. Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int. 2013;2013:564645. [PMID: 23956991 DOI: 10.1155/2013/564645] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
59 Petta S, Grimaudo S, Marco VD, Scazzone C, Macaluso FS, Cammà C, Cabibi D, Pipitone R, Craxì A. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat 2013;20:486-93. [PMID: 23730842 DOI: 10.1111/jvh.12072] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
60 White DL, Tavakoli-Tabasi S, Kanwal F, Ramsey DJ, Hashmi A, Kuzniarek J, Patel P, Francis J, El-Serag HB. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther 2013;38:28-37. [PMID: 23710689 DOI: 10.1111/apt.12341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
61 Zhu M, Xu LM. Relationship between vitamin D and chronic liver diseases. Shijie Huaren Xiaohua Zazhi 2013; 21(18): 1714-1719 [DOI: 10.11569/wcjd.v21.i18.1714] [Reference Citation Analysis]
62 Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601-613. [PMID: 23622244 DOI: 10.1016/j.cell.2013.03.028] [Cited by in Crossref: 425] [Cited by in F6Publishing: 465] [Article Influence: 42.5] [Reference Citation Analysis]
63 Branch AD, Kang M, Hollabaugh K, Wyatt CM, Chung RT, Glesby MJ. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. Am J Clin Nutr 2013;98:423-9. [PMID: 23739141 DOI: 10.3945/ajcn.112.048785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
64 Rau M, Baur K, Geier A. Host genetic variants in the pathogenesis of hepatitis C. Viruses 2012;4:3281-302. [PMID: 23342360 DOI: 10.3390/v4123281] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
65 Chopra A, Klein PL, Drinnan T, Lee SS. How to optimize HCV therapy in genotype 1 patients: management of side-effects. Liver Int 2013;33 Suppl 1:30-4. [PMID: 23286843 DOI: 10.1111/liv.12080] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
66 Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol 2013;58:184-9. [PMID: 22871501 DOI: 10.1016/j.jhep.2012.07.026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
67 Estrabaud E, Vidaud M, Marcellin P, Asselah T. Genomics and HCV infection: progression of fibrosis and treatment response. J Hepatol 2012;57:1110-25. [PMID: 22659520 DOI: 10.1016/j.jhep.2012.05.016] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
68 Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, Ceriani E, Fornasiere E, Pasino M, Ieluzzi D, Pirisi M, Toniutto P. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012;56:1641-50. [PMID: 22610885 DOI: 10.1002/hep.25848] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
69 Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol 2012;57:897-909. [PMID: 22634121 DOI: 10.1016/j.jhep.2012.04.033] [Cited by in Crossref: 150] [Cited by in F6Publishing: 152] [Article Influence: 13.6] [Reference Citation Analysis]
70 Many N, Stickel F, Schmitt J, Stieger B, Soyka M, Frei P, Götze O, Müllhaupt B, Geier A. Genetic variations in bile acid homeostasis are not overrepresented in alcoholic cirrhosis compared to patients with heavy alcohol abuse and absent liver disease. Mutagenesis 2012;27:567-72. [PMID: 22522591 DOI: 10.1093/mutage/ges020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]